331 related articles for article (PubMed ID: 33391461)
1. Extracellular-vesicles delivered tumor-specific sequential nanocatalysts can be used for MRI-informed nanocatalytic Therapy of hepatocellular carcinoma.
Wu H; Xing H; Wu MC; Shen F; Chen Y; Yang T
Theranostics; 2021; 11(1):64-78. PubMed ID: 33391461
[No Abstract] [Full Text] [Related]
2. Triggering Sequential Catalytic Fenton Reaction on 2D MXenes for Hyperthermia-Augmented Synergistic Nanocatalytic Cancer Therapy.
Liang R; Li Y; Huo M; Lin H; Chen Y
ACS Appl Mater Interfaces; 2019 Nov; 11(46):42917-42931. PubMed ID: 31635454
[TBL] [Abstract][Full Text] [Related]
3. Nanocatalysts-Augmented and Photothermal-Enhanced Tumor-Specific Sequential Nanocatalytic Therapy in Both NIR-I and NIR-II Biowindows.
Feng W; Han X; Wang R; Gao X; Hu P; Yue W; Chen Y; Shi J
Adv Mater; 2019 Feb; 31(5):e1805919. PubMed ID: 30536723
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Targeting, Tumor Microenvironment-Responsive Intelligent Nanocatalysts for Enhanced Tumor Ablation.
Feng L; Xie R; Wang C; Gai S; He F; Yang D; Yang P; Lin J
ACS Nano; 2018 Nov; 12(11):11000-11012. PubMed ID: 30339353
[TBL] [Abstract][Full Text] [Related]
5. Ultrasmall Cu
Hu R; Fang Y; Huo M; Yao H; Wang C; Chen Y; Wu R
Biomaterials; 2019 Jun; 206():101-114. PubMed ID: 30927714
[TBL] [Abstract][Full Text] [Related]
6. Nanocatalysts-augmented Fenton chemical reaction for nanocatalytic tumor therapy.
Qian X; Zhang J; Gu Z; Chen Y
Biomaterials; 2019 Aug; 211():1-13. PubMed ID: 31075521
[TBL] [Abstract][Full Text] [Related]
7. Tumor-selective catalytic nanomedicine by nanocatalyst delivery.
Huo M; Wang L; Chen Y; Shi J
Nat Commun; 2017 Aug; 8(1):357. PubMed ID: 28842577
[TBL] [Abstract][Full Text] [Related]
8. Photonic/magnetic hyperthermia-synergistic nanocatalytic cancer therapy enabled by zero-valence iron nanocatalysts.
Dai C; Wang C; Hu R; Lin H; Liu Z; Yu L; Chen Y; Zhang B
Biomaterials; 2019 Oct; 219():119374. PubMed ID: 31369897
[TBL] [Abstract][Full Text] [Related]
9. Facile engineering of silk fibroin capped AuPt bimetallic nanozyme responsive to tumor microenvironmental factors for enhanced nanocatalytic therapy.
Yang R; Fu S; Li R; Zhang L; Xu Z; Cao Y; Cui H; Kang Y; Xue P
Theranostics; 2021; 11(1):107-116. PubMed ID: 33391464
[No Abstract] [Full Text] [Related]
10. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract][Full Text] [Related]
11. Patient pIgR-enriched extracellular vesicles drive cancer stemness, tumorigenesis and metastasis in hepatocellular carcinoma.
Tey SK; Wong SWK; Chan JYT; Mao X; Ng TH; Yeung CLS; Leung Z; Fung HL; Tang AHN; Wong DKH; Mak LY; Yuen MF; Sin CF; Ng IO; Ma SKY; Lee TKW; Cao P; Zhong K; Gao Y; Yun JP; Yam JWP
J Hepatol; 2022 Apr; 76(4):883-895. PubMed ID: 34922977
[TBL] [Abstract][Full Text] [Related]
12. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy.
Fu LH; Wan Y; Qi C; He J; Li C; Yang C; Xu H; Lin J; Huang P
Adv Mater; 2021 Feb; 33(7):e2006892. PubMed ID: 33394515
[TBL] [Abstract][Full Text] [Related]
13. Nanocatalytic Tumor Therapy by Single-Atom Catalysts.
Huo M; Wang L; Wang Y; Chen Y; Shi J
ACS Nano; 2019 Feb; 13(2):2643-2653. PubMed ID: 30753056
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific nanomedicine via sequential catalytic reactions for accurate tumor therapy.
Chen L; Zhao L; Hu G; Jin R; Cai B; Bai Y; Chen X
J Mater Chem B; 2020 Aug; 8(31):6857-6865. PubMed ID: 32022092
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancer-associated hepatic stellate cells in hepatocellular carcinoma microenvironment.
Li J; Yan Y; Ang L; Li X; Liu C; Sun B; Lin X; Peng Z; Zhang X; Zhang Q; Wu H; Zhao M; Su C
Carcinogenesis; 2020 Apr; 41(2):223-234. PubMed ID: 31140556
[TBL] [Abstract][Full Text] [Related]
16. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-Mimic Hollow Mesoporous Fe-Based Nanocatalysts for Self-Amplified Chemodynamic Therapy and Metastasis Inhibition
Zuo W; Chen W; Liu J; Huang S; Chen L; Liu Q; Liu N; Jin Q; Li Y; Wang P; Zhu X
ACS Appl Mater Interfaces; 2022 Feb; 14(4):5053-5065. PubMed ID: 35040616
[TBL] [Abstract][Full Text] [Related]
18. Positive feedback nanoamplifier responded to tumor microenvironments for self-enhanced tumor imaging and therapy.
Zhang Y; Lin L; Liu L; Liu F; Sheng S; Tian H; Chen X
Biomaterials; 2019 Sep; 216():119255. PubMed ID: 31229855
[TBL] [Abstract][Full Text] [Related]
19. Photocatalysis Enhancement for Programmable Killing of Hepatocellular Carcinoma through Self-Compensation Mechanisms Based on Black Phosphorus Quantum-Dot-Hybridized Nanocatalysts.
Lan S; Lin Z; Zhang D; Zeng Y; Liu X
ACS Appl Mater Interfaces; 2019 Mar; 11(10):9804-9813. PubMed ID: 30773883
[TBL] [Abstract][Full Text] [Related]
20. Acidic pH and High-H
Lin B; Chen H; Liang D; Lin W; Qi X; Liu H; Deng X
ACS Appl Mater Interfaces; 2019 Mar; 11(12):11157-11166. PubMed ID: 30869853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]